254 related articles for article (PubMed ID: 10843746)
1. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
2. Distinctive response of thyroid-infiltrating mononuclear cells to B cell activation through CD40 and interleukin-4 in Graves' patients.
Itoh M; Uchimura K; Yamamoto K; Makino M; Imamura S; Kobayashi T; Fujiwara K; Kato T; Hayakawa N; Sawai Y; Nagasaka A; Iwase K; Nomura T; Hagino Y
Cytokine; 2002 Aug; 19(3):107-14. PubMed ID: 12242076
[TBL] [Abstract][Full Text] [Related]
3. The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.
Uchimura K; Itoh M; Yamamoto K; Imamura S; Makino M; Kato T; Fujiwara K; Sawai Y
Clin Exp Immunol; 2002 May; 128(2):308-12. PubMed ID: 11985521
[TBL] [Abstract][Full Text] [Related]
4. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
[TBL] [Abstract][Full Text] [Related]
5. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
6. Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
Itoh M; Uchimura K; Hayakawa N; Makino M; Hayashi R; Nagata M; Kakizawa H; Nagasaka A; Sakamoto H; Kuzuya H
Clin Exp Immunol; 1998 Aug; 113(2):309-14. PubMed ID: 9717983
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes.
Brodie C; Oshiba A; Renz H; Bradley K; Gelfand EW
Eur J Immunol; 1996 Jan; 26(1):171-8. PubMed ID: 8566063
[TBL] [Abstract][Full Text] [Related]
8. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
9. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
10. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
[TBL] [Abstract][Full Text] [Related]
11. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease.
Paterson RL; Lack G; Domenico JM; Delespesse G; Leung DY; Finkel TH; Gelfand EW
Eur J Immunol; 1996 Sep; 26(9):1979-84. PubMed ID: 8814234
[TBL] [Abstract][Full Text] [Related]
12. Increase of peripheral B lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
[TBL] [Abstract][Full Text] [Related]
13. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
14. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
15. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
16. IL-21 effects on human IgE production in response to IL-4 or IL-13.
Wood N; Bourque K; Donaldson DD; Collins M; Vercelli D; Goldman SJ; Kasaian MT
Cell Immunol; 2004; 231(1-2):133-45. PubMed ID: 15919378
[TBL] [Abstract][Full Text] [Related]
17. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.
Karanikas G; Schuetz M; Wahl K; Paul M; Kontur S; Pietschmann P; Kletter K; Dudczak R; Willheim M
Clin Endocrinol (Oxf); 2005 Aug; 63(2):191-6. PubMed ID: 16060913
[TBL] [Abstract][Full Text] [Related]
18. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
Heine G; Anton K; Henz BM; Worm M
Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis.
Misaki T; Konishi J; Nakashima T; Iida Y; Kasagi K; Endo K; Uchiyama T; Kuma K; Torizuka K
Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
